3D Printed Prosthetics Global Market Report 2023 – By Material (Polypropylene, Polyethylene, Acrylics, Polyurethane), By Type (Sockets, Limbs, Joints, Covers, Other Types), By End-User (Hospitals, Rehabilitation Centers, Prosthetic Clinics) – Market Size, Trends, And Global Forecast 2023-2032

Orthopedic prosthetics are artificial devices or limbs that are used to replace a missing body part that has been lost due to an accident, trauma, or congenital conditions to improve a person's lifestyle and function. The main types of products in 3D orthopedics/prosthetics are upper extremity prosthetics, lower extremity prosthetics, sockets, and others. Upper extremity prosthetics are upper limb prostheses that can be used anywhere from the shoulder joint to the fingers. The different technologies include conventional, electric-powered, hybrid orthopedics prosthetics and are used by several sectors such as hospitals, prosthetics centers, rehabilitation centers, and others. The global 3D orthpedics/prosthetics market is segmented – 1) By Product Type: Upper Extremity Prosthetics, Lower Extremity Prosthetics, Sockets, Other Types 2) By Technology: Conventional, Electric-powered, Hybrid Orthopedic Prosthetics 3) By End User: Hospitals, Prosthetic Centers, Rehabilitation Center, Other End-Users The global 3D orthopedics/prosthetics market size grew from $2.98 billion in 2022 to $3.2 billion in 2023 at a compound annual growth rate (CAGR) of 7.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The 3D orthopedics/prosthetics market size is expected to grow to $3.97 billion in 2027 at a CAGR of 5.6%. The increase in number of trauma cases and accidental injuries is contributing to the growth of the 3D orthopedics/prosthetics market. The use of artificial limbs (prostheses) to improve the function and lifestyle of people who have lost limbs is known as orthopedic prosthetics. To match the functional needs of the individual, the prosthesis must be a unique mixture of appropriate alignment, construction, materials, and design. For instance, according to Hanger, Inc., a US-based company that provides prosthetic and orthotic care devices, in April 2021, the number of Americans living with the loss of a limb due to trauma cases and accidental injuries is more than 2 million, and by the year 2050, a staggering 3.6 million people will be living with limb loss in the USA. Therefore, the increasing number of trauma cases and accidental injuries drives the growth of 3D orthopedics/prosthetics market. Major players in the 3D orthopedics/prosthetics market are Advanced Arm Dynamics, Arthrex, Blatchford, DJO Global Inc., Exactech Inc., Fillauer LLC, Globus Medical, Hanger Inc., Orthopediatrics, Integra LifeSciences Holdings Corporation, Össur, Otto Bock, Pega Medical, Smith & Nephew, Wishbone Medical, Zimmer Biomet, Wright Medical, DePuy Synthes, Mobius Bionics, NuVasive Inc., Steeper Group, and Stryker Corp. The growing technological advancements are a key trend gaining popularity in the 3D orthopedics/prosthetics market. Major research institutes and corporations are focusing on developing new technological solutions for 3D orthopedics/prosthetics to give users more control and precision when using prosthetic hands. For instance, in March 2020, US researchers at the University of Michigan’s Medical School developed nerve interface technology that allows Prosthetics to control artificial limbs with their thoughts. Muscle grafts, electrodes, and machine learning algorithms are used in the nerve interface technology to strengthen the feeble nerve signals originating from the amputee's residual limb so that the bionic hand can absorb them in real-time. In January 2020, Essentium, Inc., a US-based 3D printing solutions provider collaborated with Vorum for an undisclosed amount. This partnership provides a 3D printing solution for orthotics & prosthetics customers to succeed in producing mass-customized orthopedics/prosthetics products with speed and scalability. This collaboration also incorporates the Essentium High-Speed Extrusion (HSE) 3D Printing Platform and materials, as well as Vorum's O&P CAD/CAM solutions and SurePath methodology. Vorum is a Canada-based manufacturer of 3D printed orthopedics/prosthetics devices. North America was the largest region in the 3D orthopedics/prosthetics market in 2022. Asia-Pacific is expected to be the fastest-growing region in the 3D orthopedics/prosthetics market share during the forecast period. The regions covered in 3D orthopedics/prosthetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the 3D orthopedics/prosthetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The 3D orthopedics/prosthetics market consists of sales of implants, medical devices, surgical planning models, orthotics, and prosthetics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The 3D orthopedics/prosthetics market research report is one of a series of new reports from The Business Research Company that provides 3D orthopedics/prosthetics market statistics, including 3D orthopedics/prosthetics industry global market size, regional shares, competitors with a 3D orthopedics/prosthetics market share, detailed 3D orthopedics/prosthetics market segments, market trends and opportunities, and any further data you may need to thrive in the 3D orthopedics/prosthetics industry. This 3D orthopedics/prosthetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Prosthetics & orthotics refer to artificial prosthetics and orthotics medical devices used to support deformity parts of the human body. The purpose of prosthetics & orthotics devices is to fit comfortably and allows people with limb amputations or physical impairments of their limbs or spine to achieve functional ability. The main types of prosthetics & orthotics market include prosthetics and orthotics. Prosthetics are artificial limbs or body parts used to replace lost body parts due to amputation or lack of development. The categories of prosthetics & orthotics include upper limb, lower limb, and spinal. Hospitals, clinics, rehabilitation centers, and others utilize prosthetics & orthotics. The different technologies used in prosthetics & orthotics include conventional, electrical-powered, and hybrid technologies. The global prosthetics and orthotics market is segmented - 1) By Type: Prosthetics, Orthotics 2) By Category: Upper limb, Lower limb, Spinal 3) By Technology: Conventional, Electric-Powered, Hybrid Orthopedic Prosthetics 4) By Application: Hospitals, Clinics, Rehabilitation Centers, Other Applications The global prosthetics & orthotics market size grew from $6.6 billion in 2022 to $6.99 billion in 2023 at a compound annual growth rate (CAGR) of 5.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global prosthetics & orthotics is expected to grow to $8.46 billion in 2027 at a CAGR of 4.9%. The increase in sports injuries and road accident cases significantly drive the prosthetics and orthotics market. Road accidents are caused by distracted driving and high speeding. These conditions cause many disabilities in the injured people, entailing the use of prosthetics and orthotics for recovery and restoring normal day-to-day function. According to the report by National Crime Records Bureau, India, In July 2021, road crash deaths in the country have increased by 1.3 percent to 1,54,732 from 1,52,780. Additionally, the leading cause of sports injuries is the year-round participation of athletes in a single sport, resulting in more injuries. For instance, In a report by National Safety Council (NSC), bicycling sports were responsible for approximately 426,000 damages in 2020, Exercise, with or without equipment, in second with about 378,000 injuries, while OHV, moped, and minibike in third with 230,000 injuries, and skateboard, scooter, and hoverboard in fourth with 218,000 injuries. Therefore, increasing sports injuries and road accident cases are expected to boost demand for prosthetics and orthotics during the forecast period. Major players in the prosthetics & orthotics market are Fillauer LLC, Bauerfeind AG, Otto Bock Healthcare GmbH, Zimmer Biomet Holdings Inc., Blatchford Limited, WillowWood Global LLC, The Ohio Willow Wood Company, Steeper Group, Johnson and Johnson, Stryker Corporation, Smith & Nephew PLC, Howard Orthopedics Inc., Shapeways Inc., Hanger Inc., and Coloplast. Technological advancement is a new trend gaining popularity in the prosthetics and orthotics market. Major companies operating in the prosthetics and orthotics market are focused on providing technologically advanced products to strengthen their market position. These companies are implementing next-generation technologies into their products and related services, such as automation, artificial intelligence (AI), microprocessor, neuromuscular signal technology, sensory control, and others, to provide smoother, more natural motions and functions. For instance, in February 2022, Ossur, an Iceland-based orthotics and prosthetics (O&P) company, launched POWER KNEE. POWER KNEE is the first actively powered microprocessor prosthetic knee for persons with limb differences or above-knee amputations. The POWER KNEE generates motion by offering active powered assistance while recognizing whether the wearer is seated or standing or walking on different surfaces, inclines, or declines. In October 2020, Proteor, a France-based international group specializing in prosthetic and orthotic solutions, acquired a portion of Freedom Innovations' array of lower limb prosthetics. With this acquisition, Proteor combines the Freedom Innovations' expertise to generate momentum to build a presence within the prosthetics and orthotics. Proteor added Freedom Innovations' flagship lower limb products to its portfolios, including Plié3 microprocessor knee, Kinnex, and Kinterra ankles, Agilix, Highlander, Dynadapt, Sierra, and Pacifica feet products. Freedom Innovations is an American brand and a part of the product portfolio from Ottobock. Ottobock is a German-based company that operates in orthopedic technology. North America was the largest region in the prosthetics orthotics market in 2022. The Asia-Pacific is expected to be the fastest-growing region in the prosthetics orthotics market share during the forecast period. The regions covered in the prosthetics and orthotics market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the prosthetics and orthotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The prosthetics & orthotics market consists of sales of orthotics such as transradial, transfemoral, transtibial, and transhumeral and prosthetics such as soft, rigid, and semi-rigid. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The prosthetics and orthotics market research report is one of a series of new reports from The Business Research Company that provides prosthetics and orthotics market statistics, including prosthetics and orthotics industry global market size, regional shares, competitors with a prosthetics and orthotics market share, detailed prosthetics and orthotics market segments, market trends and opportunities, and any further data you may need to thrive in the prosthetics and orthotics industry. This prosthetics and orthotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Orthopedic prosthetics are artificial devices that replace a missing body part that may be lost through trauma, disease, surgical removal of body appendage, disabling illness, or congenital conditions. The main product types of orthopedic prosthetics are upper extremity prosthetics, lower extremity prosthetics, sockets, and other products. Orthopedic prosthetics are artificial devices used to replace a missing body part lost due to disease, trauma, and surgical removal of body appendage, disabling illness, or congenital conditions. The technologies involved are conventional orthopedic prosthetics, electric-powered orthopedic prosthetics, and hybrid orthopedic prosthetics. The end-users are hospitals, prosthetic clinics, rehabilitation centres, and others. The global orthopedic prosthetics market is segmented - 1) By Product Type: Upper Extremity Prosthetics, Lower Extremity Prosthetics, Sockets, Other Products 2) By End Users: Hospitals, Prosthetic Clinics, Rehabilitation Center, Other End Users 3) By Technology: Conventional orthopedic prosthetics, Electric-powered orthopedic prosthetics, Hybrid orthopedic prosthetics The global orthopedic prosthetics market size will grow from $1.86 billion in 2022 to $1.96 billion in 2023 at a compound annual growth rate (CAGR) of 5.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global orthopedic prosthetics is expected to grow to $2.42 billion in 2027 at a CAGR of 5.4%. The orthopedic prosthetics market is being driven by an increasing number of trauma cases and accidental injuries. The trauma cases and accidental injuries are caused by various factors such as road accidents, sports injuries, other medical complications, and work-related accidents. Most of these injuries may require amputations and prosthetic devices to replace the lost body part. For instance, 2.1 million people are living with limb loss in the USA, and that number is expected to double by 2050. 185,000 people in the U.S have an amputation each year. This means that 300 to 500 amputations have been performed every day. Therefore, driving the demand for orthopedic prosthetics, thus growth in the orthopedic prosthetics market. Major players in the orthopedic prosthetics market are Otto Bock HealthCare GmbH, Blatchford Ltd., Zimmer Biomet Inc., DePuy Synthes, Stryker Corporation, The Ohio Willow Wood Co., Ossur, Smith and Nephew PLC., Biomet Inc., and Touch Bionics Inc. The orthopedic prosthetics market is being restrained by entry barriers due to guidelines by the FDA's regulatory control over these devices based on the risks associated with them. These devices fall into the class III category as per the FDA, which includes devices involving high risk associated with the usage. Class III devices are required to undergo a premarket approval application (PMA), which is the FDA process of scientific evaluation for assessing the safety of these devices. Such stringent guidelines associated with these devices are creating an entry barrier and thus restraining the orthopedic prosthetics market. For instance, DePuy's hip prosthetic device was denied approval by the FDA after it was assessed as unsafe, thus creating an entry barrier and restraining the market. The companies in the orthopedic prosthetics market are witnessing the emergence of 3D printed orthopedic prosthetics. 3D printing is a process that involves a digital model being transformed into a three-dimensional solid object. 3D printed orthopedic prosthetics are devices that are manufactured by the process of 3D printing. These devices have shorter lead times, lower costs and consistent quality. For instance, Zdravprint is a Russian company that is developing prosthetics for the hand, elbow, and shoulder using 3D printing technology. The orthopedic prosthetics market is regulated as per the guidelines by the food and drug administration (FDA). The FDA has subjected these devices under the class III category, which includes those devices involving a high risk associated with the usage. Class III devices are required to undergo a premarket approval application (PMA) before they can be used. PMA is the process followed by the FDA for scientific evaluation, to assess the safety of the devices. If a PMA application is found to be lacking valid clinical assessment and correct scientific reasoning, it impacts the FDA's approval and prevents the prosthetic device from being released into the market. In October 2022, Patient Square Capital, a US-based healthcare investment firm acquired Hanger Inc for $18.75 in cash per stock. The acquisition would make Hanger a private company and help it better serve its customers and continue its growth. Hanger inc is a US-based manufacturer of Orthotic and prosthetic patient care services and solutions. North America was the largest region in the global orthopedic prosthetics market in 2022. Western Europe was the second-largest region in the orthopedic prosthetics market report. The regions covered in the orthopedic prosthetics industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the orthopedic prosthetics market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The orthopedic prosthetics market consists of sales of upper extremity prosthetics, lower extremity prosthetics, sockets, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The orthopedic prosthetics market research report is one of a series of new reports from The Business Research Company that provides orthopedic prosthetics market statistics, including orthopedic prosthetics industry global market size, regional shares, competitors with a orthopedic prosthetics market share, detailed orthopedic prosthetics market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic prosthetics industry. This orthopedic prosthetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Prosthetic heart valve devices and equipment are artificial heart valves that are implanted in the heart of a patient with valvular heart disease. The main types of prosthetic heart valve devices and equipment are transcatheter heart valve, tissue heart valve, and mechanical heart valve. Transcatheter aortic valve replacement is an invasive heart procedure to replace a thickened aortic valve that will not fully open. The product types are repair products, mitral valve repair devices, and tricuspid valve repair devices. The technologies involved in prosthetic heart valve devices and equipment are biological valves and decellularized valves that are used in various applications such as hospitals and ambulatory surgery centres. The global prosthetic heart valve devices and equipment market is segmented - 1) By Type: Transcatheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve 2) By Application: Hospitals, Ambulatory Surgery Centres 3) By Product Type: Repair Products, Mitral Valve Repair Devices, Tricuspid Valve Repair Devices 4) By Technology: Biological Valve, Decellularized Valve The global prosthetic heart valve devices and equipment market size will grow from $5.04 billion in 2022 to $5.5 billion in 2023 at a compound annual growth rate (CAGR) of 9.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global prosthetic heart valve devices and equipment is expected to grow to $7.41 billion in 2027 at a CAGR of 7.7%. The rising prevalence of valvular heart disease has driven the need for transcatheter aortic valve replacement (TAVR) procedures, thus driving the prosthetic heart valve devices and equipment market. TAVR is a minimally-invasive surgical procedure done to cure aortic stenosis which is a valvular heart disease that affects the aortic valve of the heart. Aortic stenosis affects the aortic valve by hardening it, thus not allowing blood to properly flow through it and TAVR is used to replace this defective aortic valve with a transcatheter valve. According to a report from The Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) TVT Registry, volumes have grown every year. In 2021, TAVR procedures make up more than 84% of aortic valve replacement procedures in the united states. 92,000 TAVR procedures were done in 2021. As the rate of occurrence of valvular heart diseases rises, the number of TAVR procedures done can be expected to increase which also increases the demand for transcatheter valves, thus driving the market going forward. Major players in the prosthetic heart valve devices and equipment market are Boston Scientific, Edward life sciences, Medtronic, Livanova, Abbott, Jenavalve technology, Lepu medical, Cryolife, Neovasc Inc., and St. Jude medical. Prosthetic heart valve devices have stringent procedures for approval which restrains the growth of the prosthetic heart valve devices and equipment market. According to the US food and drugs administration (FDA), randomized clinical trials are required for any medical device, to test for its safety standards. A randomized clinical trial is a clinical method of study that involves the separation of groups of patient subjects using random selection. This is done to compare different medicines and treatment methods fairly with no room for bias and also to detect side effects if any. However, these random clinical trials take long periods. Companies in this market are increasingly preferring polymer valves over traditional mechanical and bio-prosthetic valves/tissue valves. Polymer heart valves are prosthetic heart valves made of polymeric materials and have better functioning than tissue and mechanical heart valves. Mechanical heart valves come with a lifelong requirement of using blood-thinning medication to prevent blood clotting whereas bioprosthetic heart valves come with a short life span that needs several replacements and have a risk of valve degradation. Polymeric heart valves on the other hand support better blood flow and reduce the risk of blood clotting and therefore do not have the disadvantages of tissue and mechanical valves. Therefore, various companies are focusing on the development of polymeric heart valve technologies, For instance, in July 2022, Shanghai Medics, a Shanghai-based medical technology company developed new synthetic heart valve. The new valve is developed using polymer nanomaterial and has a longer lasting life of 20 to 25 years. The prosthetic heart valve devices and equipment market is monitored by regulatory bodies such as FDA in the US and The Central Drugs Standard Control Organization (CDSCO). For instance, CDSCO issued a notice regarding the classification of the risk levels of different medical devices. Under this classification, prosthetic heart valves are considered a class D or high-risk device. Similarly, for manufacturers to produce and sell prosthetic valve devices in India, they need to sign forms MD-7 and MD-8 which come under the direct purview of the central government of India. Form MD-7 is used to register prosthetic valve manufacturers in India and form MD-8 is used by prosthetic valve manufacturers to apply for loans. North America was the largest region in global prosthetic heart valve devices and equipment market in 2022. Western Europe was the second-largest region in prosthetic heart valve devices and equipment market. The regions covered in the global prosthetic heart valve devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the prosthetic heart valve devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The prosthetic heart valve devices and equipment market consist of sales of mechanical heart valves, transcatheter heart valves, and tissue heart valves that are used for heart patients. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The prosthetic heart valve devices and equipment market research report is one of a series of new reports from The Business Research Company that provides prosthetic heart valve devices and equipment market statistics, including prosthetic heart valve devices and equipment industry global market size, regional shares, competitors with a prosthetic heart valve devices and equipment market share, detailed prosthetic heart valve devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the prosthetic heart valve devices and equipment industry. This prosthetic heart valve devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Neuroprosthetics is the study of neuroprostheses and brain-machine interfaces. Neuroprosthetic devices substitute the cognitive or sensory functions that have been impaired due to nervous system disorders. They encompass various artificial devices or systems that can enhance the output or input of a neural system. The major purpose of neuroprosthetics is to allow brain-injured patients to participate in day-to-day life and improve their quality of life. The main types of neuroprosthetics are motor neuroprosthetics, auditory neuroprosthetics/ cochlear implants, visual neuroprosthetics/ retinal implants, and cognitive neuroprosthetics. As an orthosis, motor neuroprosthesis (MN) includes electrical stimulation of brain areas to promote the activities and involvement of persons who have had a stroke in their natural environment. The various techniques used are spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation, and transcranial magnetic stimulation which are applied in various disorders such as motor neuron disorders, physiological disorders, and cognitive disorders. The global neuroprosthetics market is segmented - 1) By Type: Motor Neuroprosthetics, Auditory Neuroprosthetics/ Cochlear implants, Visual Neuroprosthetics/ Retinal implants, Cognitive Neuroprosthetics 2) By Technique: Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Transcranial Magnetic Stimulation 3) By Application: Motor Neuron Disorders, Physiological Disorders, Cognitive Disorders The global neuroprosthetics market size grew from $8.09 billion in 2022 to $9.24 billion in 2023 at a compound annual growth rate (CAGR) of 14.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the neuroprosthetics market is expected to grow to $16.03 billion in 2027 at a CAGR of 14.7%. The rising patient population suffering from neurological disorders and nerve injuries is expected to propel the growth of the neuroprosthetics market. Neurological disorders are referred to as disorders that affect the brain and the nerves present in the human body and the spinal cord. Nerve injuries are the damages caused to nerves due to pressure, cuts, or stretching during an accident or any unpredicted event. Neuroprosthetics help patients with such disorders and injuries to restore their lost motor and sensory functions. For instance, according to the world Health Oganization (WHO), a Switzerland-based health agency of the united nations, in 2022, 50 million people globally were suffering from epilepsy, nearly 80% of them were living in low and middle-income countries. Therefore, the growing patient population suffering from neurological disorders and nerve injuries is driving the growth of the neuroprosthetics market. Major players in the neuroprosthetics market are Medtronic plc, Cochlear Ltd., Abbott Laboratories, Boston Scientific, LivaNova PLC., Second Sight Medical Products Inc., MED-EL, Retina Implant AG, Sonova, Neuropace, NDI Medical LLC, Demant AS, Oticon, St. Jude Medical Inc. and Biomet Inc. Technological advancements are shaping the neuroprosthetics market. Technological advancement is defined as a discovery of knowledge that advances technology to provide an enhanced product to the customers. For instance, in July 2021, the University of California San Francisco Parnassus Campus (UCSF), a US-based academic medical center, developed Speech Neuroprosthesis. The new achievement was developed by researchers of UCSF, which enabled paralysis patients to directly translate the signals from their brain to the vocal tract, which appear as text on the screen. The technology used is Brain-Computer Interface Restoration of Arm and Voice which uses human vocabulary with advanced computer algorithms that are used to recognize brain activity. In February 2021, Flow Neuroscience, a Sweden-based developer of a brain stimulation device, acquired Halo Neuroscience, for an undisclosed amount. With this acquisition, Flow Neuroscience aims at providing more personalized solutions related to brain disorders. Halo Neuroscience is a US-based developer of brain stimulators that develops muscle memory faster and develops and designs neuroprosthetics. North America was the largest region in the neuroprosthetics market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuroprosthetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the neuroprosthetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The neuroprosthetics market includes revenues earned by entities by peripheral nerve, brain-computer interface, electro stimulation, neurostimulation, cochlear implant, stimulation, femoral nerve and carbon nanotube. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The neuroprosthetics market research report is one of a series of new reports from The Business Research Company that provides neuroprosthetics market statistics, including neuroprosthetics industry global market size, regional shares, competitors with a neuroprosthetics market share, detailed neuroprosthetics market segments, market trends and opportunities, and any further data you may need to thrive in the neuroprosthetics industry. This neuroprosthetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

3D printed medical devices are artificial devices that replace a missing body part or biological structure and are manufactured by laying successive layers of material using inputs from a digital 3D model. The main types of 3D printed medical devices are implants, surgical instruments, prosthetics, tissue engineering devices, and others. The 3D-printed implants are medical implants that are made using 3D printing technology to create complex geometries. These are made up of raw materials such as plastics, biomaterial inks, and metals and alloys. The technologies involved in 3D printed medical devices are fused deposition modeling, digital light processing, stereolithography, and selective laser melting. These provide applications in orthopedic, spinal, dental, hearing aids, and others that are used by end-users such as hospitals, diagnostics centres, academic institutions, and others. The global 3D printed medical devices market is segmented – 1) By Type: Implants, Surgical instruments, Prosthetics, Tissue engineering devices, Other Types 2) By Application: Orthopedic, Spinal, Dental, Hearing Aids, Other Applications 3) By Technology: Fused Deposition Modelling, Digital Light Processing, Stereolithography, Selective Laser melting 4) By Raw Material: Plastics, Biomaterial inks, Metals and Alloys 5) By End User: Hospitals, Diagnostics Centres, Academic Institutions, Other End Users The global 3d printed medical devices market size grew from $2.87 billion in 2022 to $3.57 billion in 2023 at a compound annual growth rate (CAGR) of 24.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global 3d printed medical devices is expected to grow to $9.09 billion in 2027 at a CAGR of 26.3%. The increasing prevalence of osteoarthritis and similar musculoskeletal conditions is one of the major factors driving the growth of the 3D printed medical devices market. Osteoarthritis is a disorder that damages the joint cartilage and surrounding tissues causing pain, stiffness, and loss of joint function to the person affected by it. The 3D printing medical devices enable the creation of a replica of a patient's joint, which can provide surgeons with a crucial piece of information that might not be visible on a 2-dimensional scan. The chance of developing osteoarthritis increases with age. For instance, according to the US National Library of Medicine report, by 2040, it is estimated that approximately 78 million (26%) US adults aged 18 years and above will be projected to have doctor-diagnosed arthritis. Thereby driving the adoption of 3D printed medical devices, positively impacting the 3d printed medical devices market growth. Major players in the 3D printed medical devices market are 3D Systems Corporation, EnvisionTEC, Stratasys Ltd., Arcam AB, Cyfuse Biomedical, Materialise NV, Organovo Holdings, EOS GmbH, FabRx Ltd., and Concept Laser. Biocompatibility issues related to 3D printed medical devices restrict the growth of the 3D printed medical devices market. Biocompatibility implies the properties that make a material or a device compatible with the human body. If the material used for the preparation of a 3D printed implant device is not compatible with the patients' biomechanics, then patients may suffer side effects such as abnormal growth of bone and bleeding. Among the most common metal used in the manufacturing of 3D printed medical devices is Titanium. Though Titanium offers reliability and accuracy in creating medical-grade products, some human bodies tend to reject titanium as its chemical composition can inhibit the bone and tissue from interacting with the implant. Apart from these other reasons which may contribute to the failure of metallic implants that are either caused by the material properties of the metal (e.g., high stiffness, high corrosion rate, and toxicity) itself or by the exposure of the bone to infected metal implants i.e., infection. The increasing use of 3D printing technology in the spine industry is one of the latest trends in the 3D printed medical devices market. The spine industry is adopting 3D printing to produce new innovative products that can promote bone ingrowth and improve implant fixation to spine bone, reducing the number of manufacturing steps, thereby making the 3D printing process more cost-effective in several cases. For instance, Medtronic launched its titanium 3D printed platform – TiONIC Technology. TiONIC Technology is a 3D printed technique that uses laser methods to create implants with enhanced surface textures. Artic-L is the first implant created by the company using TiONIC Technology. The implant is made up of titanium and is designed to be used by surgeons in spine surgery. In addition to that, K2M’s Lamellar, introduced its 3D Titanium Technology to create a 3D spinal implant. The 3D printing medical device using titanium technology uses an advanced 3D printing method to create structures that were once considered impractical with traditional manufacturing techniques. The implants use titanium powder and are associated with bone growth activity. Food and Drug Administration (FDA) has a Centre for Device and Radiological Health (CDRH) to regulate the firm which manufacture, repackage, relabel and/or import 3D printing medical devices in the US. FDA provides manufacturers with a draft with guidance that includes recommendations for device design, manufacturing, and testing considerations during the development of 3D printing medical devices. Section F of the 'Technical Considerations for Additive Manufactured Medical Device' draft, requires the manufacturers to evaluate the biocompatibility of the final finished device as described in the guidance "Use of International Standard ISO-10993". The guidelines also require the manufacturer of the 3D printing devices to mention the additional information in the label if any toxic chemical additives such as certain additives, catalysts, binding and curing agents, uncured monomers, and plasticizers are used in making 3D printing medical devices. In July 2020, Medtronic, an American Irish-domiciled medical device company acquired Medicrea International for an undisclosed amount. The acquisition of Medicrea expands Medtronic’s already deep portfolio as this adds to their spinal solution profile as the advent of new digital technology will offer the ability to custom spinal implants. Medicrea International is a spinal surgery company with 30+ FDA-approved spinal implant technologies that have been utilized in over 150,000 spinal surgeries to date. North America was the largest region in the 3D printed medical devices market in 2022. Western Europe was the second largest region in the 3D printed medical devices market. The regions covered in the 3D printed medical devices market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the 3D printed medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The 3D printed medical devices market consists of sales of 3D printed prosthetics and implants. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The 3D printed medical devices market research report is one of a series of new reports from The Business Research Company that provides 3D printed medical devices market statistics, including 3D printed medical devices industry global market size, regional shares, competitors with a 3D printed medical devices market share, detailed 3D printed medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the 3D printed medical devices industry. This 3D printed medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical plastics refer to plastic products specifically used in the healthcare industry. Medical plastics are resistant to temperature, corrosion, and chemicals making them the right fit for use in medical applications. Medical plastics are used for manufacturing and packaging applications in medical products. The main type medical plastics are polyvinyl chloride (PVC), polypropylene (pp), engineering plastics, polyethylene (PE), polystyrene (PS), silicones and others. The polyvinyl chloride (PVC) plastic are economical and versatile thermoplastic polymers widely used in medical devices. The process technology used in medical plastics are extrusion, injection molding, blow molding and others (including rotational molding and compression molding). Medical plastics are used in medical disposables, medical instruments, prosthetics & implants, drugs packaging and others. The global medical plastics market is segmented - 1) By Type: Polyvinyl Chloride (PVC), Polypropylene (PP), Engineering Plastics, Polyethylene (PE), Polystyrene (PS), Silicones, Other Types 2) By Process Technology: Extrusion, Injection Molding, Blow Molding, Other Process Technologies 3) By Application: Medical Disposables, Medical Instruments, Prosthetics & Implants, Drugs Packaging, Other Applications The global medical plastics market size grew from $29.51 billion in 2022 to $31.75 billion in 2023 at a compound annual growth rate (CAGR) of 7.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global medical plastics is expected to grow to $44 billion in 2027 at a CAGR of 8.5%. The advancing medical plastic technology is significantly contributing to the growth of the medical plastics market. In the past few years, advancements in medical plastics technology such as injection molding, insert molding, and others along with ideas and new materials have gained popularity in the healthcare sector. Medical plastics are neutral and do not react with the physical or chemical properties of products packed or when they are implanted in the human body. Also, technique such as 3D printing has gained the popularity in the medical plastics technology. As medical plastic technology advances, there will be a significant increase in the production of medical plastics because of the advantages these advancements provide to manufacturers. For instance, according to the American Hospital Association, employing 3D anatomic models as surgical guides decreased surgery time by 62 minutes, saving $3,720 per case. Also, using 3D-generated anatomical models as guidance decreased the length of complicated surgeries by 1.5 to 2.5 hours. Therefore, the advancing medical plastic technology will propel the growth of the medical plastics market. Major players in the medical plastics market are BASF SE, Celanese Corporation, Solvay, Arkema SA, Eastman Chemical Company, Saint-Gobain Performance Plastics, Dow DuPont, Nolato AB, Mitsubishi Chemical Corporation, Exxon Mobil Corporation, Royal DSM, Spectrum Plastics Group, Emco Industrial Plastics Inc., Arthrex Inc and Danimer Scientific. Elimination single-use plastic is a key trend being followed by the companies operating in the medical plastics market due to risk of environmental harm caused by single-use. Eliminating single-use plastics is helpful to save the environment. Companies are focused on eliminating single-use plastics by introducing products that are made from eco-friendly materials and can be recycled. By launching these products, companies can increase their brand value, gain a competitive edge in the market, and capture additional market share. According to a firm that works to inspire positive change for people and the planet, Trvst Ltd., over 5 million tons of waste is generated by the hospitals each year, in which, around 25% of waste is contributed by plastic. For instance, EnviroPak LLC, a US-based manufacturer offers reusable steam sterilization pouch systems for infection control in healthcare and industries. It offers the FDA-approved EnviroPouch sterilization pouches to reduce the use of single-use plastic in hospitals as an alternative to single-use sterilization pouches. In addition, NewGen Surgical, a US-based medical device company, offers a 100% plant-based clinically designed kit packaging tray which can be recycled with paper. Additionally, it can reduce carbon-dioxide emission by 55% as compared to traditional foam trays and is easily biodegradable. In December 2021, Celanese Corporation, a US-based global technology, and specialty materials company acquired the Santoprene TPV elastomers business of Exxon Mobil Corporation for a total deal value of $1.15 billion. This deal enables Celanese Corporation to expand its portfolio of engineered solutions to their customers with the addition of the Santoprene business. The Santoprene TPV (thermoplastic vulcanizates) business of ExxonMobil is a proven solution for challenging applications in diverse markets such as healthcare, automotive, building and construction, industry, and consumer products. Exxon Mobil Corporation is an a US-based oil and gas company. Asia-Pacific was the largest region in the medical plastics market in 2022. The regions covered in the medical plastics market research report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the medical plastics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The medical plastics market consists of sales of polycarbonate, acrylonitrile butadiene styrene (ABS), polyethylene terephthalate glycol (PETG), and polymethyl methacrylate. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The medical plastics market research report is one of a series of new reports from The Business Research Company that provides medical plastics market statistics, including medical plastics industry global market size, regional shares, competitors with a medical plastics market share, detailed medical plastics market segments, market trends and opportunities, and any further data you may need to thrive in the medical plastics industry. This medical plastics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical equipment are devices that can be instrument, apparatus or machine that can be used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for health purpose. The main types of medical equipment are in-vitro diagnostics, dental equipment and supplies, ophthalmic devices, diagnostic imaging equipment, cardiovascular devices, hospital supplies, surgical equipment, orthopedic devices, patient monitoring devices, diabetes care devices, nephrology and urology devices, ENT devices, anesthesia and respiratory devices, neurology devices, and wound care devices. In-vitro diagnostics are tests done on samples like blood or tissue that is taken from the human body. In-vitro diagnostics will detect diseases or other conditions and are used to monitor a person’s overall health to cure, treat, or prevent diseases. The type of expenditure involved is public and private. The various product are instruments/equipment and disposables. The various end users involved are hospitals and clinics, homecare, diagnostics centres, and others. The global medical equipment market is segmented - 1) By Type: In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic Devices, Patient Monitoring Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices 2) By Type of Expenditure: Public, Private 3) By Product: Instruments/Equipment, Disposables 4) By End User: Hospitals And Clinics, Homecare, Diagnostics Centers, Other End Users Subsegments Covered: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment, Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment, Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment, X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment, Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment, Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment, Surgical Sutures And Staples, Handheld Surgical Devices And Equipment, Electrosurgical Devices And Equipment, Joint Reconstruction Devices And Equipment, Spinal Surgery Devices And Equipment, Trauma Fixation Devices And Equipment, Orthobiologics Devices And Equipment, Arthroscopy Devices And Equipment, Orthopedic Braces And Support Devices And Equipment, Craniomaxillofacial (CMF) Devices And Equipment, Orthopedic Prosthetics, Orthopedic Accessories,, Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment, Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters, Dialysis Devices And Equipment, Urinary Stone Treatment Devices And Equipment, Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment, Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment, Endoscopy Devices And Equipment, Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints, Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables, Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devices, Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices The global medical equipment market grew from $639.75 billion in 2022 to $695.05 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global medical equipment is expected to grow to $922.39 billion in 2027 at a CAGR of 7.3%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally, by the year 2020. This is increasing the demand for medical devices used in the diagnosis, prognosis, and treatment of several diseases, thereby driving the demand for medical equipment. These factors are expected to increase the patient pool globally, thereby driving the growth of the medical equipment market during the forecast period. Major companies in the medical equipment market include Medtronic Inc., Abbott Laboratories, Johnson & Johnson, Cardinal Health, Inc., Becton Dickinson, Siemens AG, STRYKER CORPORATION, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., and Boston Scientific Corporation. Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. For instance, according to cookieyed data 2021, in the US, PwC reported that 68% of 200 businesses surveyed intended to spend between $1 million and $10 million to comply with GDPR regulations. The GDPR regulation is an EU law on data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts a strain on investments relating to new product development, thereby affecting the growth of the medical equipment market. Device performance and patient data are available to healthcare service providers and are helping them to improve patient monitoring and overall care quality. Some companies are integrating medical equipment market data with EMR (Electronic Medical Records) to improve transparency and collaboration. As consumer wearables are becoming more common, patient data volumes are increasing and companies are investing in deploying data management, warehousing, and security technologies. For example, Medtronic launched a tool to augment their cardiac devices to securely transfer device data to doctors and allow them to monitor the critical health indicators of their patients. North America was the largest region in the global medical equipment market in 2022. Asia-Pacific was the second largest region in the global medical equipment market share. The regions covered in the medical equipment market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the medical equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical equipment market consists of sales of devices used in the diagnosis, treatment and monitoring of medical conditions. The market includes diagnostic devices, imaging devices, surgical devices and patient monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in the medical equipment market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified medical equipment market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the medical equipment market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The medical equipment market research report is one of a series of new reports from The Business Research Company that provides medical equipment market statistics, including medical equipment industry global medical equipment market size, regional shares, competitors with a medical equipment market share, detailed medical equipment market segments, medical equipment market trends and opportunities, and any further data you may need to thrive in the medical equipment industry. This medical equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.